118 related articles for article (PubMed ID: 6477833)
1. Bone marrow histology in myelodysplastic syndromes. II. Prognostic value of abnormal localization of immature precursors in MDS.
Tricot G; De Wolf-Peeters C; Vlietinck R; Verwilghen RL
Br J Haematol; 1984 Oct; 58(2):217-25. PubMed ID: 6477833
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors in the myelodysplastic syndromes: importance of initial data on peripheral blood counts, bone marrow cytology, trephine biopsy and chromosomal analysis.
Tricot G; Vlietinck R; Boogaerts MA; Hendrickx B; De Wolf-Peeters C; Van den Berghe H; Verwilghen RL
Br J Haematol; 1985 May; 60(1):19-32. PubMed ID: 3859319
[TBL] [Abstract][Full Text] [Related]
3. The myelodysplastic syndromes: different evolution patterns based on sequential morphological and cytogenetic investigations.
Tricot G; Boogaerts MA; De Wolf-Peeters C; Van den Berghe H; Verwilghen RL
Br J Haematol; 1985 Apr; 59(4):659-70. PubMed ID: 3857071
[TBL] [Abstract][Full Text] [Related]
4. Update on the prognostic implication of morphology, histology, and karyotype in primary myelodysplastic syndromes.
Verhoef G; De Wolf-Peeters C; Kerim S; Van De Broeck J; Mecucci C; Van den Berghe H; Boogaerts M
Hematol Pathol; 1991; 5(4):163-75. PubMed ID: 1794966
[TBL] [Abstract][Full Text] [Related]
5. Abnormal localization of immature precursors (ALIP) in the bone marrow of myelodysplastic syndromes: current state of knowledge and future directions.
Mangi MH; Salisbury JR; Mufti GJ
Leuk Res; 1991; 15(7):627-39. PubMed ID: 1861544
[TBL] [Abstract][Full Text] [Related]
6. The histological characterization of ALIP in the myelodysplastic syndromes.
De Wolf-Peeters C; Stessens R; Desmet V; Tricot G; Verwilghen RL
Pathol Res Pract; 1986 Aug; 181(4):402-7. PubMed ID: 3763479
[TBL] [Abstract][Full Text] [Related]
7. Additional prognostic value of bone marrow histology in patients subclassified according to the International Prognostic Scoring System for myelodysplastic syndromes.
Verburgh E; Achten R; Maes B; Hagemeijer A; Boogaerts M; De Wolf-Peeters C; Verhoef G
J Clin Oncol; 2003 Jan; 21(2):273-82. PubMed ID: 12525519
[TBL] [Abstract][Full Text] [Related]
8. Prognostic evaluation of ALIP and CD34 immunostaining in IPSS-R subgroups of myelodysplastic syndromes.
Xiong B; Nie Y; Tang Z; Xue M; Zuo X
Pathology; 2017 Aug; 49(5):526-533. PubMed ID: 28669578
[TBL] [Abstract][Full Text] [Related]
9. The role of bone marrow study in diagnosis and prognosis of myelodysplastic syndrome.
Saad ST; Vassallo J; Arruda VA; Lorand-Metze I
Pathologica; 1994 Feb; 86(1):47-51. PubMed ID: 8072801
[TBL] [Abstract][Full Text] [Related]
10. [Analysis on laboratory and clinical characteristics in 65 cases of myelodysplastic syndrome].
Chen BA; Gao C; Ding J; Ding JH; Sun YY; Zhao G; Cheng J; Wang J; Bao W; Song HH; Xia GH; Ma JL; Wu LL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1472-6. PubMed ID: 20030929
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow biopsy in myelodysplastic syndromes: morphological characteristics and contribution to the study of prognostic factors.
Ríos A; Cañizo MC; Sanz MA; Vallespí T; Sanz G; Torrabadella M; Gomis F; Ruiz C; San Miguel JF
Br J Haematol; 1990 May; 75(1):26-33. PubMed ID: 2375920
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow histology in myelodysplastic syndromes. I. Histological findings in myelodysplastic syndromes and comparison with bone marrow smears.
Tricot G; De Wolf-Peeters C; Hendrickx B; Verwilghen RL
Br J Haematol; 1984 Jul; 57(3):423-30. PubMed ID: 6589011
[TBL] [Abstract][Full Text] [Related]
13. The diagnostic and prognostic value of bone marrow immunostaining in myelodysplastic syndromes.
Lambertenghi Deliliers G; Annaloro C; Soligo D; Oriani A
Leuk Lymphoma; 1998 Jan; 28(3-4):231-9. PubMed ID: 9517495
[TBL] [Abstract][Full Text] [Related]
14. [Bone marrow histological changes in myelodysplastic syndrome and its clinical significance].
Liu XF; Wang BM; Yi FH
Zhonghua Nei Ke Za Zhi; 1991 Nov; 30(11):675-7, 729. PubMed ID: 1815870
[TBL] [Abstract][Full Text] [Related]
15. Risk assessment in myelodysplastic syndromes: value of clinical, hematologic and bone marrow histologic findings at presentation.
Morra E; Lazzarino M; Castello A; Inverardi D; Coci A; Alessandrino EP; Brusamolino E; Bernasconi P; Orlandi E; Bonfichi M
Eur J Haematol; 1990 Aug; 45(2):94-100. PubMed ID: 2209826
[TBL] [Abstract][Full Text] [Related]
16. [Correlation between ALIP-like cluster and fibrous proliferation in bone marrow of patients with acute myeloid leukemia in CR phase].
Zhang J; Yu YH; Wu ZT; Zhai YM; Wang H; Liu SH; Tao Y; Shi J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Feb; 22(1):40-3. PubMed ID: 24598648
[TBL] [Abstract][Full Text] [Related]
17. Cytohematologic and cytogenetic prognostic factors at diagnosis and in the evolution in 46 primary myelodysplastic syndromes.
González Manso AI; García Marcilla A; Barreiro E; Gilsanz F
Cancer Genet Cytogenet; 1992 Jul; 61(2):174-82. PubMed ID: 1638500
[TBL] [Abstract][Full Text] [Related]
18. [Influence of pre-ALIP number and its distance from trabeculae on AML relapse].
Yu YH; Zhang J; Wu ZT; Yuan YH; Zhai YM; Tao Y; Hou J; Shi J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Apr; 20(2):242-5. PubMed ID: 22541074
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of chromosome karyotype between myelodysplastic syndrome and acute leukemia patients confirmed at the same period].
Jiang M; Wen BZ; Li L; Chen S; Cheng H; Hao JP; Chen R; Wang L; Zhao F
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):387-92. PubMed ID: 24763010
[TBL] [Abstract][Full Text] [Related]
20. Therapy-related myelodysplastic syndromes: FAB classification, bone marrow histology, and immunohistology in the prognostic assessment.
Orazi A; Cattoretti G; Soligo D; Luksch R; Lambertenghi-Deliliers G
Leukemia; 1993 Jun; 7(6):838-47. PubMed ID: 7684797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
